Piper Sandler's analyst Adam Maeder has revised the price target for Intuitive Surgical (ISRG, Financial) from $670 to $575 while maintaining an Overweight rating. This adjustment comes despite the company's robust first-quarter performance, which exceeded expectations on both revenue and earnings.
During the recent quarterly report, Intuitive Surgical's management provided an optimistic outlook by increasing the full-year 2025 procedure growth guidance. The projected year-over-year growth has been adjusted from 13%-16% to a more promising range of 15%-17%. This change underscores the company's strong momentum in its operations and market presence.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 26 analysts, the average target price for Intuitive Surgical Inc (ISRG, Financial) is $609.15 with a high estimate of $700.00 and a low estimate of $470.00. The average target implies an upside of 27.24% from the current price of $478.74. More detailed estimate data can be found on the Intuitive Surgical Inc (ISRG) Forecast page.
Based on the consensus recommendation from 33 brokerage firms, Intuitive Surgical Inc's (ISRG, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Intuitive Surgical Inc (ISRG, Financial) in one year is $485.45, suggesting a upside of 1.4% from the current price of $478.74. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Intuitive Surgical Inc (ISRG) Summary page.
